Evaluation of Thyroid Hormone Replacement Dosing in Morbidly Obese Hypothyroid Patients after Bariatric Surgery-Induced Weight Loss

Evaluation of Thyroid Hormone Replacement Dosing in Morbidly Obese Hypothyroid Patients after Bariatric Surgery-Induced Weight Loss

The most frequent endocrine disease in obese patients is hypothyroidism. To date, there are no clear data regarding what happens to the dose of levothyroxine (LT4) after bariatric surgery (BS). The objective of the present study was to evaluate thyroid hormone replacement dose in morbidly obese hypo...

Full description

Bibliographic Details
Main Authors: Paula Juiz-Valiña, María Cordido, Elena Outeiriño-Blanco, Sonia Pértega, Paula Urones, María Jesús García-Brao, Enrique Mena, Lara Pena-Bello, Susana Sangiao-Alvarellos, Fernando Cordido
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Journal of Clinical Medicine
Subjects:
obesity
bariatric surgery
hypothyroidism
thyroid hormone replacement
Online Access:https://www.mdpi.com/2077-0383/10/16/3685

Internet

https://www.mdpi.com/2077-0383/10/16/3685

Similar Items